Peter M Neupert insider trades: Adaptive Biotechnologies (ADPT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | ADPT | ↓ Sell | 124,690 | $25.15 | $3.1M | Direct | Aug 19, 2026 (2d) |
| Aug 11, 2025 | FTRE | ↑ Buy | 62,500 | $6.51 | $407K | Direct | Aug 11, 2025 (0d) |
| Mar 10, 2025 | ADPT | ↓ Sell | 10,000 | $7.05 | $71K | Direct | Mar 12, 2025 (2d) |
| Aug 23, 2023 | FTRE | ↑ Buy | 11,000 | $25.30 | $278K | Direct | Aug 23, 2023 (0d) |
| Feb 16, 2022 | LH | ↑ Buy | 3,500 | $263.66 | $923K | Direct | Feb 18, 2022 (2d) |
| Sep 12, 2005 | AQNT | ↓ Sell | 50,000 | $19.76 | $988K | Direct | Sep 14, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADPT insiders
Open-market trades in the last 12 months
About Peter M Neupert's insider trades
Peter M Neupert is a director at Adaptive Biotechnologies (ADPT). Since Sep 12, 2005, Peter has reported 3 open-market purchases worth $1.6M and 3 sales worth $4.2M on SEC Form 4. In the last 12 months: 1 sale ($3.1M).
Their filings also include grants and awards (29 filings), option exercises (20 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.